EDGAR Filing Documents for 0001213900-23-025454

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001213900-23-025454

Filing Date

2023-03-31

Accepted

2023-03-31 16:06:22

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f10k2022_tffpharma.htm iXBRL	10-K	1746773
2	CERTIFICATE OF AMENDMENT TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORA	f10k2022ex3-2_tffpharma.htm	EX-3.2	5345
3	FORM OF WARRANT ISSUED TO INVESTORS IN NOVEMBER 2022 FOLLOW-ON OFFERING	f10k2022ex4-5_tffpharma.htm	EX-4.5	74733
4	EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN ZAMANEH MIKHAK, M.D. AND REGISTRANT	f10k2022ex10-11_tffpharma.htm	EX-10.11	70850
5	EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN HARLAN WEISMAN, M.D. AND REGISTRANT	f10k2022ex10-12_tffpharma.htm	EX-10.12	38290
6	CONSENT OF MARCUM LLP	f10k2022ex23-1_tffpharma.htm	EX-23.1	2886
7	CERTIFICATION	f10k2022ex31-1_tffpharma.htm	EX-31.1	12291
8	CERTIFICATION	f10k2022ex31-2_tffpharma.htm	EX-31.2	11977
9	CERTIFICATION	f10k2022ex32-1_tffpharma.htm	EX-32.1	12134
10	GRAPHIC	image_001.jpg	GRAPHIC	3206
11	GRAPHIC	image_002.jpg	GRAPHIC	31283
	Complete submission text file	0001213900-23-025454.txt		6329205

Data Files

Seq	Description	Document	Type	Size
12	XBRL SCHEMA FILE	tffp-20221231.xsd	EX-101.SCH	68592
13	XBRL CALCULATION FILE	tffp-20221231_cal.xml	EX-101.CAL	26757
14	XBRL DEFINITION FILE	tffp-20221231_def.xml	EX-101.DEF	237361
15	XBRL LABEL FILE	tffp-20221231_lab.xml	EX-101.LAB	505225
16	XBRL PRESENTATION FILE	tffp-20221231_pre.xml	EX-101.PRE	255336
64	EXTRACTED XBRL INSTANCE DOCUMENT	f10k2022_tffpharma_htm.xml	XML	650795

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746

Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973

TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)